StemCells (STEM) Q2/12 Results
08:13 EDT 3 Aug 2012 | Scimitar Equity Blog
A net income of $834K or $0.03 per share A net income of $834K or $0.03 per share compared to Q2/11 net loss of $4.035M or $0.29. Total revenue was $249K, compared to $234K in Q2/11. Revenue from licensing and grants was $38K and product..
Original Article: StemCells (STEM) Q2/12 Results
More From BioPortfolio on "StemCells (STEM) Q2/12 Results"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
